Are you Dr. Adler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 61 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1000 W Carson St
C1 Annex
Torrance, CA 90502Phone+1 310-222-2401Fax+1 310-320-9688
Summary
- Dr. Sharon Adler, MD is a nephrologist in Torrance, California. She is currently licensed to practice medicine in California. She is affiliated with Harbor-UCLA Medical Center and is a Professor of Medicine at UCLA.
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterFellowship, Nephrology, 1981 - 1982
Loma Linda University Health Education ConsortiumResidency, Internal Medicine, 1977 - 1980
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1976 - 1977
State University of New York Downstate Medical Center College of MedicineClass of 1976
Certifications & Licensure
CA State Medical License 1977 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- The Family Investigation of Nephropathy and Diabetes Study Start of enrollment: 1999 Oct 01
- Nephrotic Syndrome Study Network Start of enrollment: 2010 Apr 01
- Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.Brad H Rovin, Pierre M Ronco, Jack F M Wetzels, Sharon G Adler, Isabelle Ayoub
Kidney International Reports. 2024-09-01 - Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials.John M Flack, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope
Kidney Medicine. 2023-12-01 - 26 citationsPrecision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.Laura H Mariani, Sean Eddy, Fadhl M AlAkwaa, Phillip J McCown, Jennifer L Harder
Kidney International. 2023-03-01
Professional Memberships
- Fellow
